Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.2318746124335324e-56,47.688235294117646,6110.862191371727,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL8', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'FAU', 'RPS21', 'RPS24', 'RPS23']",6.695623837300598e-54,0,0,62
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.1894366824517607e-42,36.78175925925926,3528.287668157191,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'ATP5PO']",3.284155023677641e-40,0,0,49
3,Nonalcoholic fatty liver disease WP4396,8.91988070796854e-31,15.926335174953959,1101.972679041733,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'INSR', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",8.91988070796854e-29,0,0,46
4,Oxidative phosphorylation WP623,2.0614622976434788e-22,27.840747330960856,1390.1847447108657,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'ATP5PO']",1.546096723232609e-20,0,0,27
5,Mitochondrial complex I assembly model OXPHOS system WP4324,3.0473135469779744e-20,28.72566371681416,1290.8578317218714,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAF3']",1.8283881281867847e-18,0,0,24
6,Mitochondrial CIV Assembly WP4922,1.7420345246904175e-12,23.571428571428573,638.2192320121903,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14']",8.710172623452088e-11,0,0,15
7,Mitochondrial complex III assembly WP4921,1.6125206193418536e-07,27.962134251290877,437.33608707707543,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",6.91080265432223e-06,0,0,8
8,Cellular Proteostasis WP4918,7.85690357697e-06,69.57191780821918,817.7565297407165,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.000294633884136375,0,0,5
9,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0011665419138609087,41.600682593856654,280.9590099333127,"['COX8A', 'GSTP1', 'COX5A']",0.038884730462030295,0,0,3
10,Selenium Micronutrient Network WP15,0.003933625265939529,3.596024651601799,19.915481497676875,"['SELENOM', 'PRDX5', 'GPX4', 'INSR', 'SELENOW', 'TXN', 'SEPHS2', 'SELENOH']",0.11800875797818586,0,0,8
11,Nanomaterial induced apoptosis WP2507,0.0046441608567215666,7.931623931623932,42.609830500669545,"['CASP9', 'ENDOG', 'BAX', 'CYCS']",0.12403753247142023,0,0,4
12,mRNA Processing WP411,0.004961501298856809,3.137198275862069,16.64612119517924,"['SF3B5', 'LSM7', 'SNRPG', 'CD2BP2', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'SRSF9']",0.12403753247142023,0,0,9
13,Pyrimidine metabolism WP4022,0.005697803348334738,3.0603027754415475,15.814648786010922,"['POLR1B', 'POLE3', 'NME2', 'ENPP1', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.1314877695769555,0,0,9
14,Eukaryotic Transcription Initiation WP405,0.011386060040915295,4.340218321917808,19.42406323293374,"['GTF2A2', 'TAF13', 'POLR1B', 'POLR2I', 'POLR2K']",0.23053792273926418,0,0,5
15,Cholesterol Biosynthesis Pathway WP197,0.011975534025859415,5.55008547008547,24.558515151668104,"['IDI1', 'NSDHL', 'MVK', 'MSMO1']",0.23053792273926418,0,0,4
16,Serotonin Transporter Activity WP1455,0.013063815621891637,27.686541737649062,120.10169960324308,"['IL1R1', 'NOS1']",0.23053792273926418,0,0,2
17,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.013063815621891637,27.686541737649062,120.10169960324308,"['ELOB', 'ELOC']",0.23053792273926418,0,0,2
18,Dual hijack model of Vif in HIV infection WP3300,0.024961128974200667,13.841567291311755,51.08141137899641,"['ELOB', 'ELOC']",0.40665878350139595,0,0,2
19,TP53 network WP1742,0.025755056288421743,5.938566552901024,21.729953242845784,"['SUMO1', 'GADD45A', 'BAX']",0.40665878350139595,0,0,3
20,Non-small cell lung cancer WP4255,0.04033996091816185,2.6034519725557463,8.358155316281483,"['CASP9', 'EML4', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.6050994137724278,0,0,6
21,MTHFR deficiency WP4288,0.04269615222062749,4.617747440273037,14.56274293624278,"['CASP9', 'CHKA', 'CYCS']",0.6099450317232499,0,0,3
22,Apoptosis Modulation and Signaling WP1772,0.04501241986732162,2.3152920962199315,7.179296698881352,"['CASP9', 'ENDOG', 'IL1R1', 'TRADD', 'CYCS', 'BAX', 'MAP3K14']",0.6138057254634767,0,0,7
23,Acute viral myocarditis WP4298,0.054690003076207985,2.6676106427818755,7.7522748524387035,"['CASP9', 'ENDOG', 'CYCS', 'BAX', 'NOS1']",0.7133478662114084,0,0,5
24,Mitochondrial CII Assembly WP4920,0.06757663617765347,inf,inf,['SDHAF1'],0.8447079522206684,0,0,1
25,TNF-alpha signaling pathway WP231,0.07368999097582643,2.1907556197526405,5.7132459416049866,"['CASP9', 'TRADD', 'BAX', 'TXN', 'HRAS', 'MAP3K14']",0.8449254371304505,0,0,6
26,Photodynamic therapy-induced unfolded protein response WP3613,0.07604328934174055,3.4620307167235493,8.919757709901562,"['XBP1', 'DDIT3', 'PDIA6']",0.8449254371304505,0,0,3
27,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.07604328934174055,3.4620307167235493,8.919757709901562,"['CASP9', 'BAX', 'NOS1']",0.8449254371304505,0,0,3
28,Folate Metabolism WP176,0.09466840520169224,2.519036519036519,5.93831362552226,"['GPX4', 'INSR', 'NOS1', 'SLC19A1']",0.9043100395167007,0,0,4
29,Glutathione metabolism WP100,0.09730374899387248,4.611584327086883,10.744612226693967,"['GPX4', 'IDH1']",0.9043100395167007,0,0,2
30,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.09730374899387248,4.611584327086883,10.744612226693967,"['IDI1', 'MVK']",0.9043100395167007,0,0,2
31,Proteasome Degradation WP183,0.10129876805533938,2.165828339041096,4.959056060298972,"['PSMC5', 'H2AFZ', 'PSMA2', 'HLA-B', 'PSMB10']",0.9043100395167007,0,0,5
32,p38 MAPK Signaling Pathway WP400,0.10297438280011308,2.9667235494880546,6.744178572979412,"['TRADD', 'DDIT3', 'HRAS']",0.9043100395167007,0,0,3
33,Parkinson's disease pathway WP2371,0.10297438280011308,2.9667235494880546,6.744178572979412,"['CASP9', 'CYCS', 'PARK7']",0.9043100395167007,0,0,3
34,Cytosolic DNA-sensing pathway WP4655,0.10550283794361509,2.409215904868079,5.418368554221168,"['IRF3', 'TRADD', 'POLR2K', 'POLR2L']",0.9043100395167007,0,0,4
35,NO/cGMP/PKG mediated Neuroprotection WP4008,0.10550283794361509,2.409215904868079,5.418368554221168,"['CASP9', 'CAMK2A', 'CYCS', 'NOS1']",0.9043100395167007,0,0,4
36,Type 2 papillary renal cell carcinoma WP4241,0.11766117131856665,2.7686006825938567,5.9246565501307344,"['SETD2', 'ELOB', 'ELOC']",0.9325481015287775,0,0,3
37,Computational Model of Aerobic Glycolysis WP4629,0.11968634578440653,3.9522998296422487,8.390261199820445,"['LDHA', 'PFKM']",0.9325481015287775,0,0,2
38,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.12874592101134374,2.215931623931624,4.542470192745837,"['IDI1', 'NSDHL', 'MVK', 'MSMO1']",0.9325481015287775,0,0,4
39,Genotoxicity pathway WP4286,0.12874592101134374,2.215931623931624,4.542470192745837,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9325481015287775,0,0,4
40,Apoptosis WP254,0.13016945886491066,1.9794520547945205,4.0359407169310675,"['CASP9', 'IRF3', 'TRADD', 'CYCS', 'BAX']",0.9325481015287775,0,0,5
41,Acetylcholine Synthesis WP528,0.1305940159646749,13.819727891156463,28.1322932980816,['CHKA'],0.9325481015287775,0,0,1
42,DNA damage response WP707,0.14109912530001495,2.130440499671269,4.172025906347042,"['CASP9', 'GADD45A', 'CYCS', 'BAX']",0.9325481015287775,0,0,4
43,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.14109912530001495,2.130440499671269,4.172025906347042,"['IFI27L2', 'CAMK2A', 'ETS1', 'HRAS']",0.9325481015287775,0,0,4
44,Apoptosis Modulation by HSP70 WP384,0.14316918269529327,3.4578364565587734,6.721094412298354,"['CASP9', 'CYCS']",0.9325481015287775,0,0,2
45,Unfolded protein response WP4925,0.14316918269529327,3.4578364565587734,6.721094412298354,"['XBP1', 'DDIT3']",0.9325481015287775,0,0,2
46,Oxidative Damage WP3941,0.14913257733848362,2.4422806665328247,4.647463719401383,"['CASP9', 'GADD45A', 'CYCS']",0.9325481015287775,0,0,3
47,miRNA regulation of DNA damage response WP1530,0.15390048106194534,2.051282051282051,3.8388699740175936,"['CASP9', 'GADD45A', 'CYCS', 'BAX']",0.9325481015287775,0,0,4
48,Amyotrophic lateral sclerosis (ALS) WP2447,0.16577653097286388,2.3063139931740615,4.144710541300895,"['CASP9', 'BAX', 'NOS1']",0.9325481015287775,0,0,3
49,Glycolysis and Gluconeogenesis WP534,0.16577653097286388,2.3063139931740615,4.144710541300895,"['LDHA', 'MPC2', 'PFKM']",0.9325481015287775,0,0,3
50,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.1671187585723084,1.9777777777777779,3.5383445004643512,"['CASP9', 'BAX', 'NOS1', 'HRAS']",0.9325481015287775,0,0,4
51,Ciliary landscape WP4352,0.18560758867337618,1.4297669284048218,2.407899897602219,"['POM121', 'EXOSC4', 'NDUFA5', 'CAMK2A', 'CD2BP2', 'COPS7A', 'MYL6B', 'SNRPB2', 'COX6C', 'LSM4']",0.9325481015287775,0,0,10
52,Effects of nitric oxide WP1995,0.18935915644756987,6.909013605442177,11.49735703180214,['NOS1'],0.9325481015287775,0,0,1
53,Gene regulatory network modelling somitogenesis  WP2854,0.18935915644756987,6.909013605442177,11.49735703180214,['RIPPLY2'],0.9325481015287775,0,0,1
54,Peroxiredoxin 2 induced ovarian failure WP4873,0.18935915644756987,6.909013605442177,11.49735703180214,['BAX'],0.9325481015287775,0,0,1
55,Imatinib and Chronic Myeloid Leukemia WP3640,0.19246315091586466,2.765587734241908,4.55727531704251,"['SPRED2', 'GADD45A']",0.9325481015287775,0,0,2
56,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.1946771758301939,1.8454700854700854,3.019950502355163,"['CASP9', 'GADD45A', 'CYCS', 'BAX']",0.9325481015287775,0,0,4
57,Endometrial cancer WP4155,0.1946771758301939,1.8454700854700854,3.019950502355163,"['CASP9', 'GADD45A', 'BAX', 'HRAS']",0.9325481015287775,0,0,4
58,DNA Replication WP466,0.2005324463054614,2.0751706484641637,3.3343410725198295,"['RFC3', 'GMNN', 'UBA52']",0.9325481015287775,0,0,3
59,MET in type 1 papillary renal cell carcinoma WP4205,0.2005324463054614,2.0751706484641637,3.3343410725198295,"['RPL11', 'ETS1', 'HRAS']",0.9325481015287775,0,0,3
60,Modulators of TCR signaling and T cell activation WP5072,0.2005324463054614,2.0751706484641637,3.3343410725198295,"['NDUFB10', 'ELOB', 'MAP3K14']",0.9325481015287775,0,0,3
61,Statin inhibition of cholesterol production WP430,0.2178571008102253,2.5138609261266844,3.830912716152208,"['APOC1', 'PLTP']",0.9325481015287775,0,0,2
62,Ebstein-Barr virus LMP1 signaling WP262,0.2178571008102253,2.5138609261266844,3.830912716152208,"['TRADD', 'MAP3K14']",0.9325481015287775,0,0,2
63,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2178571008102253,2.5138609261266844,3.830912716152208,"['CASP9', 'BAX']",0.9325481015287775,0,0,2
64,miRNA regulation of p53 pathway in prostate cancer WP3982,0.2178571008102253,2.5138609261266844,3.830912716152208,"['CASP9', 'BAX']",0.9325481015287775,0,0,2
65,Melanoma WP4685,0.23832604220879183,1.677078477078477,2.405124435843819,"['GADD45A', 'BAX', 'ETS1', 'HRAS']",0.9325481015287775,0,0,4
66,DNA Mismatch Repair WP531,0.24351171257972687,2.3040885860306646,3.254733041056313,"['RFC3', 'POLE3']",0.9325481015287775,0,0,2
67,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.24415851651706716,4.605442176870748,6.493386120967464,['RIPPLY2'],0.9325481015287775,0,0,1
68,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.24415851651706716,4.605442176870748,6.493386120967464,['BAX'],0.9325481015287775,0,0,1
69,Nucleotide Excision Repair WP4753,0.25533620307265753,1.8038284611960231,2.462540002105471,"['RFC3', 'POLE3', 'GTF2H5']",0.9325481015287775,0,0,3
70,Fas ligand pathway and stress induction of heat shock proteins WP314,0.26927608660593744,2.1265889136417244,2.790123106512196,"['CASP9', 'CYCS']",0.9325481015287775,0,0,2
71,Gastric Cancer Network 2 WP2363,0.26927608660593744,2.1265889136417244,2.790123106512196,"['RFC3', 'SNURF']",0.9325481015287775,0,0,2
72,Monoamine Transport WP727,0.26927608660593744,2.1265889136417244,2.790123106512196,"['IL1R1', 'NOS1']",0.9325481015287775,0,0,2
73,7q11.23 copy number variation syndrome WP4932,0.27351609248788983,1.471874089186826,1.9081299445796744,"['ATP5PO', 'ATP5MC3', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.9325481015287775,0,0,5
74,Signal transduction through IL1R WP4496,0.29501846487231087,1.9744463373083476,2.4102408646883187,"['IL1R1', 'MAP3K14']",0.9325481015287775,0,0,2
75,BDNF-TrkB Signaling WP3676,0.29501846487231087,1.9744463373083476,2.4102408646883187,"['HOMER1', 'HRAS']",0.9325481015287775,0,0,2
76,CAMKK2  Pathway WP4874,0.29501846487231087,1.9744463373083476,2.4102408646883187,"['FIS1', 'NOS1']",0.9325481015287775,0,0,2
77,SARS-CoV-2 mitochondrial interactions WP5038,0.29501846487231087,1.9744463373083476,2.4102408646883187,"['NDUFB9', 'IRF3']",0.9325481015287775,0,0,2
78,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.2952592992218948,3.453656462585034,4.2131201062207,['IDH1'],0.9325481015287775,0,0,1
79,Insulin signaling in adipocytes (diabetic condition) WP3635,0.2952592992218948,3.453656462585034,4.2131201062207,['INSR'],0.9325481015287775,0,0,1
80,Insulin signaling in adipocytes (normal condition) WP3634,0.2952592992218948,3.453656462585034,4.2131201062207,['INSR'],0.9325481015287775,0,0,1
81,Kennedy pathway from sphingolipids WP3933,0.2952592992218948,3.453656462585034,4.2131201062207,['CHKA'],0.9325481015287775,0,0,1
82,Leptin Insulin Overlap WP3935,0.2952592992218948,3.453656462585034,4.2131201062207,['INSR'],0.9325481015287775,0,0,1
83,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.2952592992218948,3.453656462585034,4.2131201062207,['VEGFB'],0.9325481015287775,0,0,1
84,Alzheimer's disease WP2059,0.2994672566270593,1.4950334950334951,1.8026369269587217,"['CASP9', 'ATP5MD', 'CYCS', 'NOS1']",0.9325481015287775,0,0,4
85,Vitamin D-sensitive calcium signaling in depression WP4698,0.3206243400985509,1.8425894378194208,2.0959180700576883,"['GPX4', 'ATP2B4']",0.9325481015287775,0,0,2
86,GABA receptor Signaling WP4159,0.3206243400985509,1.8425894378194208,2.0959180700576883,"['SLC32A1', 'AP2M1']",0.9325481015287775,0,0,2
87,Insulin Signaling WP481,0.32265582769244666,1.3173241852487136,1.4901163772049888,"['XBP1', 'INSR', 'ENPP1', 'MAP3K14', 'HRAS', 'PFKM']",0.9325481015287775,0,0,6
88,Serotonin and anxiety WP3947,0.3429107353255568,2.7625850340136053,2.956753634059729,['CRH'],0.9325481015287775,0,0,1
89,Cytosine methylation WP3585,0.3429107353255568,2.7625850340136053,2.956753634059729,['IDH1'],0.9325481015287775,0,0,1
90,ERK Pathway in Huntington's Disease WP3853,0.3429107353255568,2.7625850340136053,2.956753634059729,['HRAS'],0.9325481015287775,0,0,1
91,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.3429107353255568,2.7625850340136053,2.956753634059729,['MAFF'],0.9325481015287775,0,0,1
92,Mevalonate pathway WP3963,0.3429107353255568,2.7625850340136053,2.956753634059729,['MVK'],0.9325481015287775,0,0,1
93,Osteoclast Signaling WP12,0.3429107353255568,2.7625850340136053,2.956753634059729,['ATP6V1G1'],0.9325481015287775,0,0,1
94,Overview of nanoparticle effects WP3287,0.3429107353255568,2.7625850340136053,2.956753634059729,['BAX'],0.9325481015287775,0,0,1
95,Disruption of postsynaptic signaling by CNV WP4875,0.34599473225453214,1.72721465076661,1.8331477112000614,"['HOMER1', 'CAMK2A']",0.9325481015287775,0,0,2
96,Histone Modifications WP2369,0.34599473225453214,1.72721465076661,1.8331477112000614,"['SETD2', 'SET']",0.9325481015287775,0,0,2
97,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.34599473225453214,1.72721465076661,1.8331477112000614,"['LDHA', 'BAX']",0.9325481015287775,0,0,2
98,16p11.2 proximal deletion syndrome WP4949,0.3464435629408849,1.3823931623931625,1.465385621302187,"['KCTD13', 'TMEM219', 'CCT7', 'CCT4']",0.9325481015287775,0,0,4
99,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.3498063560107482,1.48080204778157,1.5553982596769946,"['IRF3', 'TRADD', 'PIN1']",0.9325481015287775,0,0,3
100,AGE/RAGE pathway WP2324,0.36870506883350745,1.4295633753089325,1.4263586172788683,"['CASP9', 'INSR', 'CYCS']",0.9325481015287775,0,0,3
101,Synaptic Vesicle Pathway WP2267,0.36870506883350745,1.4295633753089325,1.4263586172788683,"['SLC32A1', 'PARK7', 'AP2M1']",0.9325481015287775,0,0,3
102,White fat cell differentiation WP4149,0.37104461885533513,1.6254133680729532,1.6114883820992274,"['IRF3', 'DDIT3']",0.9325481015287775,0,0,2
103,Androgen receptor signaling pathway WP138,0.3778686906187732,1.3162393162393162,1.2809753209088275,"['SUMO1', 'BAG1', 'PARK7', 'FKBP4']",0.9325481015287775,0,0,4
104,Serotonin and anxiety-related events WP3944,0.387345288475846,2.30187074829932,2.183183450762399,['CRH'],0.9325481015287775,0,0,1
105,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.387345288475846,2.30187074829932,2.183183450762399,['NSDHL'],0.9325481015287775,0,0,1
106,EDA signaling in hair follicle development WP3930,0.387345288475846,2.30187074829932,2.183183450762399,['SOSTDC1'],0.9325481015287775,0,0,1
107,Glycolysis in senescence WP5049,0.387345288475846,2.30187074829932,2.183183450762399,['LDHA'],0.9325481015287775,0,0,1
108,HIF1A and PPARG regulation of glycolysis WP2456,0.387345288475846,2.30187074829932,2.183183450762399,['LDHA'],0.9325481015287775,0,0,1
109,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.387345288475846,2.30187074829932,2.183183450762399,['MAP3K14'],0.9325481015287775,0,0,1
110,Nanoparticle triggered autophagic cell death WP2509,0.387345288475846,2.30187074829932,2.183183450762399,['INSR'],0.9325481015287775,0,0,1
111,Nanoparticle triggered regulated necrosis WP2513,0.387345288475846,2.30187074829932,2.183183450762399,['TRADD'],0.9325481015287775,0,0,1
112,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.387345288475846,2.30187074829932,2.183183450762399,['IRF3'],0.9325481015287775,0,0,1
113,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.387345288475846,2.30187074829932,2.183183450762399,['LDHA'],0.9325481015287775,0,0,1
114,RAS and bradykinin pathways in COVID-19 WP4969,0.387345288475846,2.30187074829932,2.183183450762399,['NOS1'],0.9325481015287775,0,0,1
115,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.387345288475846,2.30187074829932,2.183183450762399,['ANAPC11'],0.9325481015287775,0,0,1
116,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.39570150577487645,1.534923339011925,1.423019945235555,"['HOMER1', 'HRAS']",0.9325481015287775,0,0,2
117,Base Excision Repair WP4752,0.39570150577487645,1.534923339011925,1.423019945235555,"['NEIL2', 'POLE3']",0.9325481015287775,0,0,2
118,Glycosylation and related congenital defects WP4521,0.39570150577487645,1.534923339011925,1.423019945235555,"['DPAGT1', 'MAGT1']",0.9325481015287775,0,0,2
119,Exercise-induced Circadian Regulation WP410,0.40616397849161123,1.3370031927777166,1.204637621182775,"['IDI1', 'SUMO1', 'GSTP1']",0.9325481015287775,0,0,3
120,DNA Repair Pathways Full Network WP4946,0.4095070100924345,1.2121485219899062,1.0822077243126087,"['RFC3', 'NEIL2', 'CENPX', 'POLE3', 'GTF2H5']",0.9325481015287775,0,0,5
121,EGF/EGFR signaling pathway WP437,0.4095070100924345,1.2121485219899062,1.0822077243126087,"['NDUFA13', 'CAMK2A', 'NEDD8', 'HRAS', 'AP2M1']",0.9325481015287775,0,0,5
122,"GPCRs, Class A Rhodopsin-like WP455",0.4095070100924345,1.2121485219899062,1.0822077243126087,"['NPFFR1', 'GPR22', 'NPY1R', 'OR6A2', 'GPR19']",0.9325481015287775,0,0,5
123,Integrated Cancer Pathway WP1971,0.41990412702947516,1.4539585761678473,1.2616418217684566,"['CASP9', 'BAX']",0.9325481015287775,0,0,2
124,Transcription factor regulation in adipogenesis WP3599,0.42877978114808957,1.9727891156462585,1.6705811464493687,['INSR'],0.9325481015287775,0,0,1
125,Fatty acid transporters WP5061,0.42877978114808957,1.9727891156462585,1.6705811464493687,['FABP6'],0.9325481015287775,0,0,1
126,Genes targeted by miRNAs in adipocytes WP1992,0.42877978114808957,1.9727891156462585,1.6705811464493687,['TMSB4X'],0.9325481015287775,0,0,1
127,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.42877978114808957,1.9727891156462585,1.6705811464493687,['HRAS'],0.9325481015287775,0,0,1
128,NO metabolism in cystic fibrosis WP4947,0.42877978114808957,1.9727891156462585,1.6705811464493687,['NOS1'],0.9325481015287775,0,0,1
129,Osteopontin Signaling WP1434,0.42877978114808957,1.9727891156462585,1.6705811464493687,['MAP3K14'],0.9325481015287775,0,0,1
130,RalA downstream regulated genes WP2290,0.42877978114808957,1.9727891156462585,1.6705811464493687,['HRAS'],0.9325481015287775,0,0,1
131,Hepatitis B infection WP4666,0.4367197382971169,1.170768516368702,0.9699391241370128,"['CASP9', 'IRF3', 'CYCS', 'BAX', 'HRAS']",0.9325481015287775,0,0,5
132,Integrated breast cancer pathway WP1984,0.4367197382971169,1.170768516368702,0.9699391241370128,"['CASP9', 'GADD45A', 'TRADD', 'BAX', 'FAU']",0.9325481015287775,0,0,5
133,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.44360126248910264,1.3810902896081771,1.1225904841583227,"['CASP9', 'NDUFA13']",0.9325481015287775,0,0,2
134,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.44360126248910264,1.3810902896081771,1.1225904841583227,"['IRF3', 'TRADD']",0.9325481015287775,0,0,2
135,Myometrial relaxation and contraction pathways WP289,0.44547345129487304,1.1354590098451562,0.9181521699832643,"['IGFBP5', 'GSTO1', 'MAFF', 'CAMK2A', 'CRH', 'NOS1']",0.9325481015287775,0,0,6
136,VEGFA-VEGFR2 Signaling Pathway WP3888,0.45814623952748473,1.057429069188651,0.8253940729348366,"['SET', 'TXN', 'ETS1', 'PDIA6', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'CCT7', 'HRAS']",0.9325481015287775,0,0,15
137,Ferroptosis WP4313,0.4667506639212124,1.3151618398637137,1.002100812991571,"['GPX4', 'VDAC2']",0.9325481015287775,0,0,2
138,One-carbon metabolism and related pathways WP3940,0.4667506639212124,1.3151618398637137,1.002100812991571,"['GPX4', 'CHKA']",0.9325481015287775,0,0,2
139,Transcriptional cascade regulating adipogenesis WP4211,0.4674164448964581,1.7259778911564625,1.3126660323007964,['DDIT3'],0.9325481015287775,0,0,1
140,Type II diabetes mellitus WP1584,0.4674164448964581,1.7259778911564625,1.3126660323007964,['INSR'],0.9325481015287775,0,0,1
141,Cori Cycle WP1946,0.4674164448964581,1.7259778911564625,1.3126660323007964,['LDHA'],0.9325481015287775,0,0,1
142,Fluoropyrimidine Activity WP1601,0.4674164448964581,1.7259778911564625,1.3126660323007964,['GGH'],0.9325481015287775,0,0,1
143,Hypertrophy Model WP516,0.4674164448964581,1.7259778911564625,1.3126660323007964,['IL1R1'],0.9325481015287775,0,0,1
144,NRF2-ARE regulation WP4357,0.4674164448964581,1.7259778911564625,1.3126660323007964,['INSR'],0.9325481015287775,0,0,1
145,Nucleotide metabolism WP404,0.4674164448964581,1.7259778911564625,1.3126660323007964,['NME2'],0.9325481015287775,0,0,1
146,SARS coronavirus and innate immunity WP4912,0.4674164448964581,1.7259778911564625,1.3126660323007964,['IRF3'],0.9325481015287775,0,0,1
147,IL-18 signaling pathway WP4754,0.46815712646364893,1.0833248962235498,0.8221908373424249,"['ARL4D', 'NACA', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'RND2']",0.9325481015287775,0,0,8
148,Copper homeostasis WP3286,0.489318079735412,1.2552268855505653,0.897164041364125,"['COX17', 'ATOX1']",0.9325481015287775,0,0,2
149,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.489318079735412,1.2552268855505653,0.897164041364125,"['XBP1', 'DDIT3']",0.9325481015287775,0,0,2
150,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.489318079735412,1.2552268855505653,0.897164041364125,"['BANF1', 'HRAS']",0.9325481015287775,0,0,2
151,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5034439008320998,1.534013605442177,1.0527674460493932,['ENPP1'],0.9325481015287775,0,0,1
152,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5034439008320998,1.534013605442177,1.0527674460493932,['LDHA'],0.9325481015287775,0,0,1
153,IL1 and megakaryocytes in obesity WP2865,0.5034439008320998,1.534013605442177,1.0527674460493932,['IL1R1'],0.9325481015287775,0,0,1
154,Pregnane X receptor pathway WP2876,0.5034439008320998,1.534013605442177,1.0527674460493932,['PSMC5'],0.9325481015287775,0,0,1
155,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5034439008320998,1.534013605442177,1.0527674460493932,['BAX'],0.9325481015287775,0,0,1
156,DNA IR-double strand breaks and cellular response via ATM WP3959,0.511276370241877,1.2005036663950819,0.8053518737034286,"['CASP9', 'BAX']",0.9325481015287775,0,0,2
157,Small cell lung cancer WP4658,0.5294316240113928,1.061801446416831,0.6752539628364806,"['CASP9', 'GADD45A', 'CYCS', 'BAX']",0.9325481015287775,0,0,4
158,Corticotropin-releasing hormone signaling pathway WP2355,0.5304225382372447,1.0897700736482845,0.6910028774260771,"['CASP9', 'CAMK2A', 'CRH']",0.9325481015287775,0,0,3
159,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5326047056150972,1.1503407155025553,0.7246867785455905,"['IL1R1', 'MAP3K14']",0.9325481015287775,0,0,2
160,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5326047056150972,1.1503407155025553,0.7246867785455905,"['TMSB4X', 'NOS1']",0.9325481015287775,0,0,2
161,PPAR signaling pathway WP3942,0.5326047056150972,1.1503407155025553,0.7246867785455905,"['FABP6', 'PLTP']",0.9325481015287775,0,0,2
162,16p11.2 distal deletion syndrome WP4950,0.5370380740282331,1.3804421768707482,0.8582019694665137,['INSR'],0.9325481015287775,0,0,1
163,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5370380740282331,1.3804421768707482,0.8582019694665137,['IRF3'],0.9325481015287775,0,0,1
164,Kynurenine Pathway and links to Cellular Senescence WP5044,0.5370380740282331,1.3804421768707482,0.8582019694665137,['NOS1'],0.9325481015287775,0,0,1
165,Nanoparticle-mediated activation of receptor signaling WP2643,0.5370380740282331,1.3804421768707482,0.8582019694665137,['HRAS'],0.9325481015287775,0,0,1
166,Neural Crest Cell Migration during Development WP4564,0.5370380740282331,1.3804421768707482,0.8582019694665137,['CDH11'],0.9325481015287775,0,0,1
167,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5370380740282331,1.3804421768707482,0.8582019694665137,['GSTP1'],0.9325481015287775,0,0,1
168,PPAR-alpha pathway WP2878,0.5370380740282331,1.3804421768707482,0.8582019694665137,['PLTP'],0.9325481015287775,0,0,1
169,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5370380740282331,1.3804421768707482,0.8582019694665137,['HRAS'],0.9325481015287775,0,0,1
170,Allograft Rejection WP2328,0.5532878396996073,1.104190800681431,0.6535450359446031,"['CASP9', 'HLA-B']",0.9325481015287775,0,0,2
171,B Cell Receptor Signaling Pathway WP23,0.563207106884366,1.0350255972696245,0.5942163259948438,"['CAMK2A', 'ETS1', 'HRAS']",0.9325481015287775,0,0,3
172,Pancreatic adenocarcinoma pathway WP4263,0.563207106884366,1.0350255972696245,0.5942163259948438,"['CASP9', 'GADD45A', 'BAX']",0.9325481015287775,0,0,3
173,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5683630467843536,1.2547928262213977,0.7089515443191055,['HRAS'],0.9325481015287775,0,0,1
174,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.5683630467843536,1.2547928262213977,0.7089515443191055,['IRF3'],0.9325481015287775,0,0,1
175,Cell migration and invasion through p75NTR WP4561,0.5683630467843536,1.2547928262213977,0.7089515443191055,['CDH11'],0.9325481015287775,0,0,1
176,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5683630467843536,1.2547928262213977,0.7089515443191055,['CD63'],0.9325481015287775,0,0,1
177,Neural Crest Cell Migration in Cancer WP4565,0.5683630467843536,1.2547928262213977,0.7089515443191055,['CDH11'],0.9325481015287775,0,0,1
178,PDGFR-beta pathway WP3972,0.5683630467843536,1.2547928262213977,0.7089515443191055,['HRAS'],0.9325481015287775,0,0,1
179,Fragile X Syndrome  WP4549,0.5714137749518546,1.0035120435120435,0.5616071680436339,"['HOMER1', 'CAMK2A', 'DLGAP3', 'AP2M1']",0.9325481015287775,0,0,4
180,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5733154525074221,1.0615908793080855,0.5905833736465167,"['BEX3', 'ETS1']",0.9325481015287775,0,0,2
181,Complement system WP2806,0.5733154525074221,1.0615908793080855,0.5905833736465167,"['RPS19', 'TXN']",0.9325481015287775,0,0,2
182,IL-1 signaling pathway WP195,0.5733154525074221,1.0615908793080855,0.5905833736465167,"['IL1R1', 'MAP3K14']",0.9325481015287775,0,0,2
183,p53 transcriptional gene network WP4963,0.5733154525074221,1.0615908793080855,0.5905833736465167,"['GADD45A', 'BAX']",0.9325481015287775,0,0,2
184,Pathways affected in adenoid cystic carcinoma WP3651,0.5926815562819963,1.0221465076660987,0.5346828233115773,"['SETD2', 'HRAS']",0.9325481015287775,0,0,2
185,Hippo-Merlin Signaling Dysregulation WP4541,0.5945610463491757,0.985494880546075,0.5123902088570483,"['INSR', 'CDH11', 'HRAS']",0.9325481015287775,0,0,3
186,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5975718543740122,1.1500850340136055,0.5921566380226326,['HRAS'],0.9325481015287775,0,0,1
187,TLR4 Signaling and Tolerance WP3851,0.5975718543740122,1.1500850340136055,0.5921566380226326,['IRF3'],0.9325481015287775,0,0,1
188,Type II interferon signaling (IFNG) WP619,0.5975718543740122,1.1500850340136055,0.5921566380226326,['HLA-B'],0.9325481015287775,0,0,1
189,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5975718543740122,1.1500850340136055,0.5921566380226326,['B3GALT2'],0.9325481015287775,0,0,1
190,Methionine De Novo and Salvage Pathway WP3580,0.5975718543740122,1.1500850340136055,0.5921566380226326,['TXN'],0.9325481015287775,0,0,1
191,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5975718543740122,1.1500850340136055,0.5921566380226326,['HRAS'],0.9325481015287775,0,0,1
192,Proximal tubule transport WP4917,0.6113839586573491,0.985519591141397,0.48490530981723473,"['ATP6V1G1', 'ATP6V1F']",0.9325481015287775,0,0,2
193,NRF2 pathway WP2884,0.623969874922513,0.9350137621324062,0.44100222280502416,"['SLC6A16', 'GSTP1', 'MAFF', 'TXN']",0.9325481015287775,0,0,4
194,DNA damage response (only ATM dependent) WP710,0.6244160843462545,0.9404669562519392,0.4429019387279052,"['INSR', 'BAX', 'HRAS']",0.9325481015287775,0,0,3
195,Pathways in clear cell renal cell carcinoma WP4018,0.6244160843462545,0.9404669562519392,0.4429019387279052,"['SETD2', 'LDHA', 'PFKM']",0.9325481015287775,0,0,3
196,Urea cycle and associated pathways WP4595,0.6248072280242809,1.0614861329147043,0.4992297850115627,['NOS1'],0.9325481015287775,0,0,1
197,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6248072280242809,1.0614861329147043,0.4992297850115627,['HRAS'],0.9325481015287775,0,0,1
198,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6248072280242809,1.0614861329147043,0.4992297850115627,['H2AFZ'],0.9325481015287775,0,0,1
199,Heart Development WP1591,0.6248072280242809,1.0614861329147043,0.4992297850115627,['VEGFB'],0.9325481015287775,0,0,1
200,MAPK Cascade WP422,0.6248072280242809,1.0614861329147043,0.4992297850115627,['HRAS'],0.9325481015287775,0,0,1
201,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6248072280242809,1.0614861329147043,0.4992297850115627,['FERMT3'],0.9325481015287775,0,0,1
202,Target Of Rapamycin (TOR) Signaling WP1471,0.6502022870117097,0.9855442176870748,0.42424894775758343,['IDI1'],0.9378267918963882,0,0,1
203,Toll-like Receptor Signaling related to MyD88 WP3858,0.6502022870117097,0.9855442176870748,0.42424894775758343,['IRF3'],0.9378267918963882,0,0,1
204,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6502022870117097,0.9855442176870748,0.42424894775758343,['DDIT3'],0.9378267918963882,0,0,1
205,IL-2 signaling pathway WP49,0.6502022870117097,0.9855442176870748,0.42424894775758343,['HRAS'],0.9378267918963882,0,0,1
206,Melatonin metabolism and effects WP3298,0.6502022870117097,0.9855442176870748,0.42424894775758343,['CAMK2A'],0.9378267918963882,0,0,1
207,Amino Acid metabolism WP3925,0.6635341332828862,0.8898170028026597,0.36498067332891,"['LDHA', 'IDH1']",0.9378267918963882,0,0,2
208,Sleep regulation WP3591,0.6738811854227744,0.9197278911564626,0.3630179472962346,['CRH'],0.9378267918963882,0,0,1
209,Alpha 6 Beta 4 signaling pathway WP244,0.6738811854227744,0.9197278911564626,0.3630179472962346,['HRAS'],0.9378267918963882,0,0,1
210,ATM Signaling Pathway WP2516,0.6738811854227744,0.9197278911564626,0.3630179472962346,['GADD45A'],0.9378267918963882,0,0,1
211,Vitamin B12 metabolism WP1533,0.6738811854227744,0.9197278911564626,0.3630179472962346,['INSR'],0.9378267918963882,0,0,1
212,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6738811854227744,0.9197278911564626,0.3630179472962346,['IRF3'],0.9378267918963882,0,0,1
213,T-cell receptor (TCR) signaling pathway WP69,0.6796197523814741,0.8619037478705281,0.33288603838210634,"['HRAS', 'MAP3K14']",0.9378267918963882,0,0,2
214,Spinal Cord Injury WP2431,0.6922787141496526,0.8439785470502194,0.3103871530803705,"['IL1R1', 'GADD45A', 'NOS1']",0.9378267918963882,0,0,3
215,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6922787141496526,0.8439785470502194,0.3103871530803705,"['INSR', 'MAP3K14', 'HRAS']",0.9378267918963882,0,0,3
216,Ebola Virus Pathway on Host WP4217,0.6922787141496526,0.8439785470502194,0.3103871530803705,"['IRF3', 'HLA-B', 'CLEC4G']",0.9378267918963882,0,0,3
217,ErbB signaling pathway WP673,0.6950722895931387,0.8356822053585257,0.303970564879337,"['CAMK2A', 'HRAS']",0.9378267918963882,0,0,2
218,Leptin signaling pathway WP2034,0.6950722895931387,0.8356822053585257,0.303970564879337,"['BAX', 'HRAS']",0.9378267918963882,0,0,2
219,Endothelin Pathways WP2197,0.6959597148152902,0.8621386054421769,0.3124937775649921,['NPY1R'],0.9378267918963882,0,0,1
220,Ethanol effects on histone modifications WP3996,0.6959597148152902,0.8621386054421769,0.3124937775649921,['SLC19A1'],0.9378267918963882,0,0,1
221,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6959597148152902,0.8621386054421769,0.3124937775649921,['IRF3'],0.9378267918963882,0,0,1
222,PDGF Pathway WP2526,0.6959597148152902,0.8621386054421769,0.3124937775649921,['HRAS'],0.9378267918963882,0,0,1
223,Retinoblastoma gene in cancer WP2446,0.7099036959758042,0.8110031065236998,0.2778707160033196,"['RFC3', 'H2AFZ']",0.9378267918963882,0,0,2
224,Ras signaling WP4223,0.7161013894274121,0.8225538971807629,0.2746783155617132,"['GNG10', 'INSR', 'ETS1', 'HRAS']",0.9378267918963882,0,0,4
225,Bladder cancer WP2828,0.7165458664418067,0.8113245298119248,0.2704250285740361,['HRAS'],0.9378267918963882,0,0,1
226,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7165458664418067,0.8113245298119248,0.2704250285740361,['HRAS'],0.9378267918963882,0,0,1
227,miRNA regulation of prostate cancer signaling pathways WP3981,0.7165458664418067,0.8113245298119248,0.2704250285740361,['CASP9'],0.9378267918963882,0,0,1
228,Aryl Hydrocarbon Receptor Pathway WP2873,0.7357403560600604,0.766156462585034,0.23511656260801725,['BAX'],0.9378267918963882,0,0,1
229,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7357403560600604,0.766156462585034,0.23511656260801725,['MAP3K14'],0.9378267918963882,0,0,1
230,Cardiac Progenitor Differentiation WP2406,0.7357403560600604,0.766156462585034,0.23511656260801725,['MESP1'],0.9378267918963882,0,0,1
231,IL17 signaling pathway WP2112,0.7357403560600604,0.766156462585034,0.23511656260801725,['MAP3K14'],0.9378267918963882,0,0,1
232,Interleukin-11 Signaling Pathway WP2332,0.7357403560600604,0.766156462585034,0.23511656260801725,['HRAS'],0.9378267918963882,0,0,1
233,Pre-implantation embryo WP3527,0.7357403560600604,0.766156462585034,0.23511656260801725,['DDIT3'],0.9378267918963882,0,0,1
234,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7357403560600604,0.766156462585034,0.23511656260801725,['CAMK2A'],0.9378267918963882,0,0,1
235,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7377570762918254,0.7657580919931857,0.23289818182505342,"['BAX', 'HRAS']",0.9378267918963882,0,0,2
236,Pathways Regulating Hippo Signaling WP4540,0.7377570762918254,0.7657580919931857,0.23289818182505342,"['INSR', 'CDH11']",0.9378267918963882,0,0,2
237,G Protein Signaling Pathways WP35,0.750808453223263,0.7449698420737603,0.21351186955301635,"['GNG10', 'HRAS']",0.9499627477457796,0,0,2
238,Common Pathways Underlying Drug Addiction WP2636,0.7536371132116518,0.7257429287504475,0.2052722572233055,['CAMK2A'],0.9499627477457796,0,0,1
239,Aryl Hydrocarbon Receptor Netpath WP2586,0.7703237379331347,0.6893707482993198,0.17988744568165316,['HRAS'],0.9510169604112774,0,0,1
240,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7703237379331347,0.6893707482993198,0.17988744568165316,['IGFBP5'],0.9510169604112774,0,0,1
241,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7703237379331347,0.6893707482993198,0.17988744568165316,['CASP9'],0.9510169604112774,0,0,1
242,IL-3 signaling pathway WP286,0.7703237379331347,0.6893707482993198,0.17988744568165316,['HRAS'],0.9510169604112774,0,0,1
243,Peptide GPCRs WP24,0.7703237379331347,0.6893707482993198,0.17988744568165316,['NPY1R'],0.9510169604112774,0,0,1
244,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7858819262518938,0.6564625850340136,0.15817381886369716,['BAX'],0.9662482699818367,0,0,1
245,TGF-beta Receptor Signaling WP560,0.8003878677615486,0.6265460729746444,0.13950601812262983,['HRAS'],0.9760827655628641,0,0,1
246,Kit receptor signaling pathway WP304,0.8003878677615486,0.6265460729746444,0.13950601812262983,['HRAS'],0.9760827655628641,0,0,1
247,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8079556379522225,0.65587734241908,0.13986461382405008,"['CASP9', 'HRAS']",0.9770939856161523,0,0,2
248,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8139126160674134,0.5992309967465247,0.12338302249087814,['MAP3K14'],0.9770939856161523,0,0,1
249,Metabolic reprogramming in colon cancer WP4290,0.8139126160674134,0.5992309967465247,0.12338302249087814,['LDHA'],0.9770939856161523,0,0,1
250,Metapathway biotransformation Phase I and II WP702,0.8167530610857413,0.6769428747272422,0.13702574817028793,"['GPX4', 'GSTO1', 'GSTP1']",0.9770939856161523,0,0,3
251,Circadian rhythm related genes WP3594,0.8214025581016083,0.6965703775830359,0.13704462355472388,"['HOMER1', 'CRH', 'RPS27A', 'UBA52']",0.9770939856161523,0,0,4
252,Vitamin D Receptor Pathway WP2877,0.8248863444640142,0.665941869426401,0.12820024714096506,"['IGFBP5', 'GADD45A', 'SOSTDC1']",0.9770939856161523,0,0,3
253,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8265224344816019,0.5741921768707483,0.10939981232398258,['HRAS'],0.9770939856161523,0,0,1
254,Nuclear Receptors Meta-Pathway WP2882,0.8272729078216757,0.7398757599788528,0.14029571588945872,"['PSMC5', 'SLC6A16', 'GSTP1', 'MAFF', 'BAX', 'TXN', 'PLTP']",0.9770939856161523,0,0,7
255,22q11.2 copy number variation syndrome WP4657,0.8363636818880444,0.6119250425894378,0.1093459471292633,"['RANBP1', 'MRPL40']",0.9839572728094641,0,0,2
256,Breast cancer pathway WP4262,0.8402303961366844,0.6449712030716723,0.1122760347018007,"['GADD45A', 'BAX', 'HRAS']",0.984644995472677,0,0,3
257,TGF-beta Signaling Pathway WP366,0.8449547986079647,0.5985482556847641,0.10083870901645463,"['SUMO1', 'ETS1']",0.9862027846520547,0,0,2
258,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8492402961938013,0.5298927263212978,0.08659141219141606,['HRAS'],0.9862027846520547,0,0,1
259,Senescence and Autophagy in Cancer WP615,0.853134531697184,0.5857406937547573,0.09303789670708842,"['IGFBP5', 'HRAS']",0.9862027846520547,0,0,2
260,Prader-Willi and Angelman Syndrome WP3998,0.8594597095643012,0.5102040816326531,0.07727108768145248,['SNURF'],0.9862027846520547,0,0,1
261,Male infertility WP4673,0.8609191347889599,0.5734667802385008,0.08587934510178222,"['INSR', 'NOS1']",0.9862027846520547,0,0,2
262,Cardiac Hypertrophic Response WP2795,0.8689874755225334,0.491921768707483,0.06907888488642358,['MAP3K14'],0.9862027846520547,0,0,1
263,Phosphodiesterases in neuronal function WP4222,0.8689874755225334,0.491921768707483,0.06907888488642358,['NOS1'],0.9862027846520547,0,0,1
264,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8778703301765718,0.47490030494956603,0.06185879647369497,['IDI1'],0.9862027846520547,0,0,1
265,Oncostatin M Signaling Pathway WP2374,0.8778703301765718,0.47490030494956603,0.06185879647369497,['HRAS'],0.9862027846520547,0,0,1
266,AMP-activated protein kinase (AMPK) signaling WP1403,0.8861518567362913,0.4590136054421769,0.055479573212492354,['INSR'],0.9862027846520547,0,0,1
267,Translation Factors WP107,0.8938726976695838,0.4441518542901031,0.04983024499195981,['EEF1B2'],0.9862027846520547,0,0,1
268,Neural Crest Differentiation WP2064,0.8938726976695838,0.4441518542901031,0.04983024499195981,['ETS1'],0.9862027846520547,0,0,1
269,G1 to S cell cycle control WP45,0.9010707527942201,0.430218962585034,0.0448165535824804,['GADD45A'],0.9862027846520547,0,0,1
270,MAPK Signaling Pathway WP382,0.904434303012698,0.6126926369863014,0.061542285829938016,"['IL1R1', 'GADD45A', 'DDIT3', 'HRAS', 'MAP3K14']",0.9862027846520547,0,0,5
271,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9077813643591607,0.41713048855906,0.04035809120041047,['ENPP1'],0.9862027846520547,0,0,1
272,Endochondral Ossification WP474,0.9077813643591607,0.41713048855906,0.04035809120041047,['ENPP1'],0.9862027846520547,0,0,1
273,Cell cycle WP179,0.9108058041218171,0.49105621805792166,0.04587720818352885,"['GADD45A', 'ANAPC11']",0.9862027846520547,0,0,2
274,Chemokine signaling pathway WP3929,0.9108058041218171,0.49105621805792166,0.04587720818352885,"['GNG10', 'HRAS']",0.9862027846520547,0,0,2
275,Endoderm differentiation WP2853,0.9157056988526957,0.4823814220389133,0.04247863122237947,"['TCEAL2', 'NME1']",0.9862027846520547,0,0,2
276,Glioblastoma signaling pathways WP2261,0.9198698583905459,0.39319727891156464,0.03284104668779392,['HRAS'],0.9862027846520547,0,0,1
277,Mesodermal commitment pathway WP2857,0.9203521007852464,0.47400575691711216,0.03934198671252176,"['SETD2', 'RPL38']",0.9862027846520547,0,0,2
278,Integrin-mediated Cell Adhesion WP185,0.9253071300721034,0.3822278911564626,0.029672184565842967,['HRAS'],0.9862027846520547,0,0,1
279,Prolactin Signaling Pathway WP2037,0.9253071300721034,0.3822278911564626,0.029672184565842967,['HRAS'],0.9862027846520547,0,0,1
280,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9277906778048338,0.6002178512851973,0.044985808374845886,"['CASP9', 'GNG10', 'INSR', 'VEGFB', 'NOS1', 'HRAS']",0.9862027846520547,0,0,6
281,Head and Neck Squamous Cell Carcinoma WP4674,0.9303760262163421,0.3718514432800147,0.02683519683710355,['HRAS'],0.9862027846520547,0,0,1
282,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9303760262163421,0.3718514432800147,0.02683519683710355,['PSMC5'],0.9862027846520547,0,0,1
283,Adipogenesis WP236,0.9328862920620612,0.45052643337894827,0.03129895391789867,"['GADD45A', 'DDIT3']",0.9862027846520547,0,0,2
284,Toll-like Receptor Signaling Pathway WP75,0.9351014646367626,0.3620211242391694,0.024291703327063992,['IRF3'],0.9862027846520547,0,0,1
285,MECP2 and Associated Rett Syndrome WP3584,0.9395066802360403,0.35269492412349557,0.022008286616008583,['CAMK2A'],0.9862027846520547,0,0,1
286,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9401799880349588,0.43611584327086883,0.026901345870702906,"['CAMK2A', 'HRAS']",0.9862027846520547,0,0,2
287,Joubert Syndrome WP4656,0.9474416423754664,0.3354073336651734,0.018108620170886713,['CEP41'],0.9869183774744442,0,0,1
288,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9474416423754664,0.3354073336651734,0.018108620170886713,['MAP3K14'],0.9869183774744442,0,0,1
289,Wnt signaling WP428,0.9574385178710229,0.3124226963512678,0.013588441238334017,['CAMK2A'],0.9934442795317292,0,0,1
290,Thermogenesis WP4321,0.9603294702140048,0.3054421768707483,0.012363949667751747,['HRAS'],0.9934442795317292,0,0,1
291,Gastrin signaling pathway WP4659,0.9655364527196685,0.2923722680561586,0.010253911354772308,['HRAS'],0.9953984048656375,0,0,1
292,ESC Pluripotency Pathways WP3931,0.9739922918631804,0.2693077230892357,0.0070967672981580516,['HRAS'],0.9960324327805623,0,0,1
293,PI3K-Akt signaling pathway WP4172,0.977612469507913,0.4713037316957959,0.010671228656827448,"['CASP9', 'GNG10', 'INSR', 'VEGFB', 'HRAS']",0.9960324327805623,0,0,5
294,Regulation of toll-like receptor signaling pathway WP1449,0.9789441649540536,0.2542517006802721,0.005410646745415873,['IRF3'],0.9960324327805623,0,0,1
295,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9817104755664386,0.24511054421768708,0.004524457665579132,['HRAS'],0.9960324327805623,0,0,1
296,Focal Adhesion WP306,0.9827520003434881,0.3262350936967632,0.00567599450085064,"['VEGFB', 'HRAS']",0.9960324327805623,0,0,2
297,Regulation of Actin Cytoskeleton WP51,0.9902999369152062,0.21093668236525379,0.0020560874149792674,['TMSB4X'],0.9965037793920929,0,0,1
298,Calcium Regulation in the Cardiac Cell WP536,0.9921492897007479,0.20155562224889956,0.0015885988054134533,['CAMK2A'],0.9965037793920929,0,0,1
299,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9931821001274526,0.1957482993197279,0.0013391626486122423,['CDCA7L'],0.9965037793920929,0,0,1
300,Ciliopathies WP4803,0.9993360896393967,0.13248794663496466,8.798933217368435e-05,['CEP41'],0.9993360896393967,0,0,1
